Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2018 Aug 23;13(8):e0203174. doi: 10.1371/journal.pone.0203174

Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma

The PLOS ONE Staff
PMCID: PMC6107280  PMID: 30138452

Notice of Republication

This article was republished on August 14, 2018, to correct for errors in the Data Availability statement introduced during the production process. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.

Supporting information

S1 File. Originally published, uncorrected article.

(PDF)

S2 File. Republished, corrected article.

(PDF)

Reference

  • 1.Azuma T, Sato Y, Ohno T, Azuma M, Kume H (2018) Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma. PLoS ONE 13(7): e0199719 10.1371/journal.pone.0199719 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. Originally published, uncorrected article.

(PDF)

S2 File. Republished, corrected article.

(PDF)


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES